SCHEMBL7654358

SCHEMBL7654358

CN(C)C1CCc2[nH]c3ccc(NC(=O)c4cccc5ccccc45)cc3c2C1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 1/20 0.66
MEN1 O00255 6/20 0.48
KMT2A Q03164 6/20 0.48
STK17B O94768 1/20 0.47
STK17A Q9UEE5 1/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ULK1 O75385 1/20 0.44
DEGS1 O15121 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
CASP1 P29466 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RXFP1 Q9HBX9 1/20 0.42
TMPRSS2 O15393 1/20 0.41
HDAC1 Q13547 1/20 0.40
BRAF P15056 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656996 0.89 HTR1F (0.68) HTR1FMEN1KMT2ANPC1RAB9A
SCHEMBL7663021 0.88 HTR1F (0.67) HTR1FMEN1KMT2ANPC1RAB9A
SCHEMBL7658859 0.88 HTR1F (0.73) HTR1FMEN1KMT2ASTK17BSTK17A
SCHEMBL7665385 0.86 HTR1F (0.63) HTR1FMEN1KMT2AULK1KDM4E
SCHEMBL7660697 0.86 HTR1F (0.70) HTR1FMEN1KMT2ASTK17BSTK17A
SCHEMBL7655584 0.86 HTR1F (0.65) HTR1FMEN1KMT2ANPC1RAB9A
SCHEMBL30909043 0.86 HTR1F (0.65) HTR1FMEN1KMT2AKDM4EALDH1A1
SCHEMBL8116686 0.86 HTR1F (0.65) HTR1FMEN1KMT2AKDM4EALDH1A1
SCHEMBL7656434 0.86 HTR1F (0.68) HTR1FMEN1KMT2ANPC1RAB9A
SCHEMBL7656398 0.85 HTR1F (0.81) HTR1FMEN1KMT2ASTK17BSTK17A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0749962-B1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed